NCT05427565

Brief Summary

This study will investigate the effect of caffeine and time of day on brain excitability using excitatory brain stimulation. The investigators will recruit a healthy participant and conduct a concurrent iTBS/fNIRS protocol for 20 consecutive sessions over four weeks with or without caffeine consumption before the stimulation. Moreover, the experiment will be conducted at different times of the day (morning or afternoon)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Aug 2022

Shorter than P25 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 16, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 22, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 15, 2022

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2022

Completed
Last Updated

September 15, 2022

Status Verified

August 1, 2022

Enrollment Period

25 days

First QC Date

June 16, 2022

Last Update Submit

September 14, 2022

Conditions

Keywords

Theta-Burst stimulation (iTBS)Functional near-infrared spectroscopy (fNIRS)Concurrent TMS/fNIRSPrefrontal hemodynamic responseLongitudinal effects

Outcome Measures

Primary Outcomes (1)

  • Oxygenated hemoglobin (HbO) change compared to baseline

    iTBS-induced HbO change in the DLPFC before, during and after stimulation

    During and post TBS-fNIRS measurement, up to 1 month

Secondary Outcomes (2)

  • Deoxygenated hemoglobin (HbR) change compared to baseline

    During and post TBS-fNIRS measurement, up to 1 month

  • Oxygen saturation change compared to baseline

    During and post TBS-fNIRS measurement, up to 1 month

Study Arms (1)

Cortical hemodynamic variability of four weeks iTBS

EXPERIMENTAL

One healthy participant will be included in this study, which lasts for 4 weeks, 5 visits per week, involving 20 visits in total. The participant will receive the following instructions the night before: to take 200 mg of caffeine one hour before the visit (no other caffeine intake since the wake-up) or avoid caffeine intake at all before the visit; to attend the visit in the morning or afternoon. These assignments will be randomized in a counterbalanced manner.

Other: caffeineOther: Experimental time

Interventions

The investigators will ask participant to only intake 200 mg of caffeine one hour before the experiment (no other caffeine intake since the wake-up) or avoid caffeine intake at all before the experiment

Cortical hemodynamic variability of four weeks iTBS

The investigators will ask participant to attend the experiment in the morning or afternoon

Cortical hemodynamic variability of four weeks iTBS

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Right-handed

You may not qualify if:

  • history of epilepsy, seizures, or convulsions
  • current or past diagnosis of neurological disorders, such as head injuries, strokes, encephalitis, epilepsy, Parkinson's, or Alzheimer's
  • current or past diagnosis of psychiatric disorders, such as depression, anxiety, schizophrenia, or autism
  • with metal implants, such as a cochlear implant, neurostimulator, or cardiac pacemaker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hong Kong Polytechnic University

Hong Kong, Hong Kong

Location

MeSH Terms

Interventions

Caffeine

Intervention Hierarchy (Ancestors)

XanthinesAlkaloidsHeterocyclic CompoundsPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Georg S Kranz, PhD

    The Hong Kong Polytechnic University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: One healthy participant will undergo four weeks of concurrent TBS/fNIRS to investigate the cortical hemodynamic variability
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 16, 2022

First Posted

June 22, 2022

Study Start

August 15, 2022

Primary Completion

September 9, 2022

Study Completion

September 9, 2022

Last Updated

September 15, 2022

Record last verified: 2022-08

Locations